# IQVIA Biotech – FDA Inspection, Apr 27, 2023

Source: https://www.keypedia.com/records/fda_inspections/iqvia-biotech/a9d94f45-ee0d-4631-9d21-ac0848873351
Source feed: FDA_Inspections

> FDA inspection 1204132 of IQVIA Biotech, April 27, 2023. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204132
- Company Name: IQVIA Biotech
- Inspection Date: 2023-04-27
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1259905 - 2025-01-27](https://www.keypedia.com/records/fda_inspections/iqvia-biotech/99dc63eb-74a1-4a42-b5e1-055144af48d5)
- FDA Inspection 1224954 - 2023-12-07
- FDA Inspection 1147013 - 2021-07-13

## Related Officers

- [Investigator](https://www.keypedia.com/people/leon-l-crawley/973f0ced-69a4-4adb-9e3c-e088e78a4516)

Company: https://www.keypedia.com/companies/iqvia-biotech/e7c3ff9e-4a89-4c22-872f-7e777e400e95

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c